Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 2c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil prices steady as investors weigh US-Iran war escalation
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Pentagon reportedly locked down, hazmat teams responding
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Zimmer Biomet (ZBH) PT Lowered to $130 at Stifel
August 7, 2024 2:03 PM EDTStifel analyst Rick Wise lowered the price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $135.00) while maintaining a Buy rating.
The analyst comments "We left Zimmer's 2Q24 earnings call better-appreciating the many fundamental positives and sales growth drivers. We were reminded that over... More
